SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-020190
Filing Date
2022-11-14
Accepted
2022-11-14 18:56:26
Documents
1
Period of Report
2022-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4258
  Complete submission text file 0001567619-22-020190.txt   5675
Mailing Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065
Business Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065 (415) 529-5055
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMAGO BIOSCIENCES, INC. 329 OYSTER POINT BLVD. 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Chiang Hsiangyi (Reporting) CIK: 0001945318 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40604 | Film No.: 221388557